APhA, 12 Other Pharmacy Organizations Call for Tier 1 Priority Status for Pharmacists in Planning for the COVID-19 Vaccine
September 4, 2020
The American Pharmacists Association and 12 other pharmacy organizations today told a special committee of the National Academies of Science, Engineering and Medicine (NASEM) that pharmacists should be given tier 1 priority status in the allocation and distribution of COVID-19 vaccine(s).
September 3, 2020
All pharmacists should be in the first tier of providers for receiving the COVID-19 vaccine to ensure that pharmacists are able to continue providing critical care to their patients, said Scott J. Knoer, MS, PharmD, FASHP, in testimony this week to a committee of the National Academies of Science, Engineering and Medicine.
August 21, 2020
There are no greater public health priorities today than defeating the COVID-19 pandemic and protecting our nation from other vaccine-preventable diseases like the seasonal flu. We need all hands on deck to improve Americans’ access to life-saving vaccines during these difficult times.
In Major Win, HHS Authorizes Pharmacists to Order and Administer Vaccines to Children Nationwide During the Public Health Emergency
August 19, 2020
The American Pharmacists Association applauds today’s announcement by the U.S. Department of Health and Human Services, which authorizes licensed pharmacists to provide all vaccines recommended by the CDC’s Advisory Committee on Immunization Practices (ACIP), and approved or licensed by the FDA, to all children ages 3 to 18 during the COVID-19 pandemic, regardless of state laws and regulations to the contrary.
Dangers of Mandatory Mail Order Shine Light on the Need for Patient Pharmacy Choice and Protecting the Pharmacist-Patient Relationship
August 18, 2020
The American Pharmacists Association (APhA) is deeply concerned about anecdotal reports of disruptions in the US Postal Service delivery of medications to our members’ patients, including our nation’s veterans. While we are working to independently determine the full extent of these reported interruptions, it is crucial to note that missing medication doses can have a significant impact on a patient’s health.
APhA: Transparency, Safety and Availability Must Be Core Principles for Strengthening America’s Drug Supply Chain
August 10, 2020
The reliability, quality and safety of our nation’s drug supply chain are essential to the nation’s security and health and well-being of the American public. Therefore, we welcome comprehensive federal efforts to improve the state of our drug supply chain, particularly at a time when our health care system is under extraordinary stress.
APhA Collaborates with Walmart to Provide Free Comprehensive Opioids Training Program for All U.S. Pharmacists and Pharmacy Technicians Nationwide
August 10, 2020
As part of ongoing efforts to help curb our nation’s opioid epidemic, the American Pharmacists Association (APhA) has collaborated with Walmart to offer a free online training program on opioid stewardship to all pharmacists and pharmacy technicians around the country. The new resource for pharmacists is being launched at a time when parts of the country are experiencing increased opioid-related overdoses as access to social and treatment networks are disrupted by the Covid-19 pandemic.
July 30, 2020
Citing the continued rise in the numbers of confirmed COVID-19 cases, hospitalizations and deaths, the Board of Trustees of the American Pharmacists Association today urged the American public to take the simple actions that save lives: “Wash your hands often, avoid close contact through physical distancing, and wear a face covering.”
July 28, 2020
APhA issues statement from Scott J. Knoer, MS, PharmD, FASHP, Executive Vice President and Chief Executive Officer of the American Pharmacists Association, following the release of the HEALS Act.
APhA Urges Congress to Authorize Pharmacists’ COVID Testing and Immunization Services under Medicare in Next Pandemic Bill
July 24, 2020
In a letter delivered today to the majority and minority leaders of Congress, the American Pharmacists Association requested immediate action to address the growing need to expand COVID-19 testing and immunization services by providing all pharmacists with temporary provider status in Medicare Part B.